Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Phillip A Saccone"'
Autor:
David Lawrence, Phillip A Saccone, Neal Doran, Natassia V. Gaznick, John B. Correa, Benjamin S. McKenna, Sarah Dubrava, Robert M. Anthenelli
Publikováno v:
Nicotine Tob Res
Introduction Psychiatric and substance use disorders represent barriers to smoking cessation. We sought to identify correlates of psychiatric comorbidity (CM; 2 diagnoses) and multimorbidity (MM; 3+ diagnoses) among smokers attempting to quit and to
Autor:
Agnieszka Sulima, Kenner C. Rice, Angela M. Lindsey, Phillip A. Saccone, James H. Woods, Kathy A. Zelenock, Eric P. Prinssen, Jürgen Wichmann
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 357:17-23
Nociceptin/orphanin FQ receptor (NOP) agonists have been reported to produce antinociceptive effects in rhesus monkeys with comparable efficacy to μ-opioid receptor (MOP) agonists, but without their limiting side effects. There are also known to be
Autor:
Suzanne K. Vosburg, Kirk W. Johnson, Ziva D. Cooper, Sandra D. Comer, Jermaine D. Jones, Martina Pavlicova, Phillip A. Saccone, Diana Martinez, Maria A. Sullivan, Jeanne M. Manubay, Andrew Glass
Publikováno v:
Addiction Biology. 21:895-903
Glial activation is hypothesized to contribute directly to opioid withdrawal. This study investigated the dose-dependent effects of a glial cell modulator, ibudilast, on withdrawal symptoms in opioid-dependent volunteers after abrupt discontinuation
Autor:
Sandra D. Comer, William J. Kowalczyk, Maria A. Sullivan, Ziva D. Cooper, Jermaine D. Jones, Mary E. Smith, Suzanne K. Vosburg, Phillip A. Saccone, Verena E. Metz, Jeanne M. Manubay, Deena Peyser
Publikováno v:
Behavioural Pharmacology. 24:504-516
This double-blind, placebo-controlled study investigated the effects of oral morphine (0, 45, 135 mg/70 kg) and oral oxycodone (0, 15, 45 mg/70 kg) on buprenorphine-maintained opioid addicts. As a 3: 1 morphine : oxycodone oral dose ratio yielded equ
Autor:
Ziva D. Cooper, Suzanne K. Vosburg, Richard W. Foltin, Margaret Haney, Jermaine D. Jones, Paula Askalsky, Eric J. Rubin, Diana Martinez, Sandra D. Comer, Abigail Pines, Perrine Roux, Emily L Berkower, Phillip A. Saccone, Ellen A. Walker, Shanthi Mogali, Jeanne M. Manubay, Maria A. Sullivan
Publikováno v:
Neuropsychopharmacology. 38:2427-2438
Despite the prevalent worldwide abuse of stimulants, such as amphetamines and cocaine, no medications are currently approved for treating this serious public health problem. Both preclinical and clinical studies suggest that the opioid antagonist nal
Autor:
Xia Shao, Robert A. Koeppe, Kathy A. Zelenock, Peter J. H. Scott, James H. Woods, Angela M. Lindsey, Carole Quesada, Phillip S. Sherman, Phillip A. Saccone
The goal of this study was to evaluate the effects of intranasally administered opioids in rhesus monkeys using the tail-withdrawal assay, and to correlate these effects with measures of receptor occupancy using positron emission tomography (PET) ima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49a59b4192e5dfdc549bb35f59061f98
https://europepmc.org/articles/PMC5074481/
https://europepmc.org/articles/PMC5074481/
Autor:
Jeanne M. Manubay, Suzanne K. Vosburg, Sandra D. Comer, Claudia Tindall, Ziva D. Cooper, Jermaine D. Jones, Maria A. Sullivan, Perrine Roux, Richard W. Foltin, Phillip A. Saccone, Janet Murray, Lionel Fugon
Publikováno v:
Addiction. 107:642-649
Aims Research on drug dependence often involves the administration of drugs of abuse to experienced drug users under controlled laboratory conditions. The primary objective of this study was to assess whether participation in such research alters the
Autor:
Phillip A. Saccone, Sandra D. Comer, Ronald L. Van Heertum, Diana Martinez, Daria Orlowska, Mark Slifstein, Stephanie H. Cook, Allegra Broft, Alex Grassetti, Fei Liu
Publikováno v:
Biological Psychiatry. 71:192-198
Background Positron emission tomography (PET) imaging studies have shown that addiction to a number of substances of abuse is associated with a decrease in dopamine D 2/3 receptor binding and decreased presynaptic dopamine release in the striatum. So
Autor:
Herbert D. Kleber, Suzanne K. Vosburg, Jeanne M. Manubay, Sandra D. Comer, Maria A. Sullivan, Phillip A. Saccone, Leslie Amass, Ziva D. Cooper
Publikováno v:
Addiction. 105:709-718
BACKGROUND Sublingual buprenorphine is an effective maintenance treatment for opioid dependence, yet intravenous buprenorphine misuse occurs. A buprenorphine/naloxone formulation was developed to mitigate this misuse risk. This randomized, double-bli
Autor:
Xia Shao, Gail Winger, James H. Woods, Peter Scott, Phillip S. Sherman, Phillip A. Saccone, Carole Quesada, Michael R. Kilbourn
Publikováno v:
The FASEB Journal. 28
The nociceptin receptor (NOP) has been investigated as a potential therapeutic target for pain control. Nociceptin, the endogenous ligand for NOP, produces analgesia in rodents and primates when gi...